T1	intervention 23 38	Calendula cream
T2	control 43 56	aqueous cream
T3	condition 78 108	acute radiation skin reactions
T4	outcome-Measure 440 486	difference in proportion of patients with ARSR
T5	outcome-Measure 702 735	patient reported outcome measures
T6	outcome-Measure 737 776	Quality of Life Questionnaire (QLQ-C30)
T7	outcome-Measure 778 822	Sleep disturbances (MOS-sleep questionnaire)
T8	outcome-Measure 827 884	symptoms from the irradiated area (visual analogue scale)
T9	No-of-participants 976 979	420
T10	No-of-participants 1009 1012	411
T11	outcome 1173 1219	incidence of severe ARSR (RTOG/EORTC grade â‰¤2)
T12	intervention-value 1247 1250	23%
T13	intervention-participants 1256 1258	45
T14	control-value 1287 1290	19%
T15	control-participants 1296 1298	38
T16	intervention 241 263	Calendula Weleda cream
T17	intervention 268 279	Essex cream
T18	outcome 1431 1462	levels of skin related symptoms
